Russian tennis star, Maria Sharapova, had been cautioned about the impeding inclusion of meldonium in the World Anti-Doping Agency (WADA)'s list of banned drugs on at least five occasions before the ban was actually implemented.
The Times newspaper reported on Wednesday that the International Tennis Federation had sent the tenns player three letters informing her about WADA's decision to implement the ban from January 1 this year. Sharapova also received two letters on the same issue from the Women's Tennis Association.
Sharapova had confessed on Monday that she had tested positive for Meldonium, a drug she said she had been taking since 2006 but that was banned by WADA only this year.
More From This Section
Sharapova claimed she began taking Meldonium to address a number of health issues, such as being prone to illness, heart condition and a family history of diabetes.